Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.

NCT01933035 is registered in ClinicalTrials.gov with Beth Israel Medical Center as lead sponsor.

NCT NCT01933035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01933035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.
Lead sponsor
Beth Israel Medical Center
Phase
Observational
Overall status
Completed
Start date
October 31, 2013
Completion date
October 31, 2015
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aplastic anaemia, chemotherapy induced thrombocytopenia, immune thrombocytopenia, myelodysplasia